Ocular biometric risk factors for progression of primary angle closure disease: the Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang, N Porporato… - Ophthalmology, 2022 - Elsevier
Purpose To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …
被引用次数：43 相关文章
[HTML] nih.gov

[HTML][HTML] Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2022 - ncbi.nlm.nih.gov
Purpose: To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2022 - pure.johnshopkins.edu
Purpose: To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial.

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2021 - europepmc.org
Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The
Zhongshan Angle Closure Prevention Trial. - Abstract - Europe PMC Sign in | Create an …
[PDF] nueyecal.com

[PDF][PDF] Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang, N Porporato… - nueyecal.com
Purpose: To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang, N Porporato… - 2022 - pubmed.ncbi.nlm.nih.gov
Purpose To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2022 - aaojournal.org
Purpose To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2022 - discovery.ucl.ac.uk
PURPOSE: To assess baseline ocular biometric risk factors for progression from primary
angle closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …

Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease: The Zhongshan Angle Closure Prevention Trial

BY Xu, DS Friedman, PJ Foster, Y Jiang… - …, 2022 - aaojournal.org
Purpose To assess baseline ocular biometric risk factors for progression from primary angle
closure suspect (PACS) to primary angle closure (PAC) or acute angle closure (AAC) …